Vimarsana
Biggest News Aggregation in the World

Page 6 - Andreas Wolf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andreas Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andreas Wolf Today - Breaking & Trending Today

COMPUGROUP MEDICAL : Warburg Research maintains a Buy rating -February 07, 2024 at 05:20 am EST - Vimarsana News

COMPUGROUP MEDICAL : Warburg Research maintains a Buy rating -February 07, 2024 at 05:20 am EST

Andreas Wolf from Warburg Research retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 70.

COMPUGROUP MEDICAL : Warburg Research reiterates its Buy rating -January 30, 2024 at 05:46 am EST - Vimarsana News

COMPUGROUP MEDICAL : Warburg Research reiterates its Buy rating -January 30, 2024 at 05:46 am EST

In a research note published by Andreas Wolf, Warburg Research advises its customers to buy the stock. The target price remains unchanged at EUR 70.

Warburg Research raises target for GFT Technologies - 'Buy' - Vimarsana News

Warburg Research raises target for GFT Technologies - 'Buy'

The analyst firm Warburg Research has raised its target price for GFT Technologies from 46.50 to 47.00 euros on the occasion of a recently announced takeover and left its rating at Buy. The Colombian...

GFT TECHNOLOGIES AG : Warburg Research reiterates its Buy rating -January 26, 2024 at 06:15 am EST - Vimarsana News

GFT TECHNOLOGIES AG : Warburg Research reiterates its Buy rating -January 26, 2024 at 06:15 am EST

In his latest research note, analyst Andreas Wolf confirms his positive recommendation. The broker Warburg Research is keeping its Buy rating. The target price continues to be set at EUR 46.50.

SAP SE : Warburg Research reaffirms its Neutral rating -January 24, 2024 at 04:30 am EST - Vimarsana News

SAP SE : Warburg Research reaffirms its Neutral rating -January 24, 2024 at 04:30 am EST

Andreas Wolf from Warburg Research retains his Neutral opinion on the stock. The target price is still set at EUR 115.